Please activate JavaScript!
Please install Adobe Flash Player, click here for download

kontinenz aktuell - Ausgabe 01-2012

Titelthema kontinenz aktuell März/2012 21 (1) van der Mei IA, Simpson S Jr, Stankovich J, Taylor BV. Individual and Joint Action of Environmental Factors and Risk of MS. Neurol Clin 2011 May; 29(2):233–55. (2) Wingerchuk DM. Environmental factors in multiple sclerosis: epstein-barr virus, vitamin d, and cigaret- te smoking. Mt Sinai J Med 2011 March; 78(2): 221–30. (3) McElroy JP, Oksenberg JR. Multiple sclerosis genetics 2010. Neurol Clin 2011 May;29(2):219-31. (4) Ramagopalan SV, Meier UC, Conacher M, Ebers GC, Giovannoni G, Crawford DH, McAulay KA. Role of the HLA System in the Association Between Multiple Sclerosis and Infectious Mononucleosis. Arch Neurol 2011 April;68(4):469-72. (5) Zhang Q, Lin CY, Dong Q, Wang J, Wang W. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: A meta-analysis of non-family-based studies. Autoimmun Rev 2011 April 2. (6) Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007 September;6(9):773-81. (7) Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 2011 March;82(3):317-22. (8) Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC. V itamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 2011 March 25. (9) Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007 June;13(5):610-5. (10 Zamboni P, Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010 December; 25(6):269-79. (11) Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemio-logy 2011;36(2):109-20. (12) Greer JM, McCombe PA. Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms. J Neuroimmunol 2011 April 6. (13) McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 July;50(1):121-7. (14) Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multi- ple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 December;58(6):840-6. (15) Khan F, Pallant JF, Shea TL, Whishaw M. Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort. Disabil Rehabil 2009;31(19): 1567-76. (16) Rantell A. Lower urinary tract symptoms in women with multiple sclerosis: 2. Br J Nurs 2009 August 13;18(15):920, 922-0, 925. (17) Pohar SL, Jones CA, Warren S, Turpin KV, Warren K. Health status and health care utilization of multi- ple sclerosis in Canada. Can J Neurol Sci 2007 May;34(2):167-74. (18) Koch T, Kralik D, Eastwood S, Schofield A. Breaking the silence: women living with multiple sclerosis and urinary incontinence. Int J Nurs Pract 2001 February;7(1):16-23. (19) Luoto E, Jussilainen M, Sandell S. (Intermittent self-catheterization in multiple sclerosis). Sairaanhoitaja 1993;(1):17-20. (20) Lemack GE, Hawker K, Frohman E. Incidence of upper tract abnormalities in patients with neurovesi- cal dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation. Urology 2005 May;65(5):854-7. (21) Petersen T, Pedersen E. Neurourodynamic evaluation of voiding dysfunction in multiple sclerosis. Acta Neurol Scand 1984 June;69(6):402-11. (22) Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Finazzi AE, Collura G, Vespasiani G. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 1999 April;80(4):437-41. (23) Welz-Barth A, Fusgen I, Melchior HJ. 1999 rerun of the 1996 German Urinary Incontinence Survey: will doctors ever ask? World J Urol 2000 December;18(6):436-8. (24) Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van KP. Good urodynamic practices: uroflowmetry, filling cysto-metry, and pressure-flow studies. Neurourol Urodyn 2002; 21(3):261-74. Reference List Dr. med. Andreas Wiedemann Urologische Klinik, Ev. Krankenhaus Witten gGmbH Lehrstuhl für Geriatrie, Universität Witten-Herdecke Pferdebachstr. 27, 58455 Witten E-Mail: awiedemann@diakonie-ruhr.de